Conferences
EAU 2016 Informed decision-making for prostate-specific antigen screening - Session Highlights
March 12, 2016
EAU 2016 Correlation between stage shift and differences in mortality between the two study arms of the ERSPC - Session Highlights
March 12, 2016
EAU 2016 18-year follow up of the Gothenburg randomized population-based prostate cancer screening trial - Session Highlights
March 12, 2016
ASCO GU 2016 Standards in First-line Chemotherapy for High-Risk GCT: Does this Include Dose Intensification? - Session Highlights
January 19, 2016
ASCO GU 2016 More CNS Events With Enzalutamide Vs. Bicalutamide Treatment of mCRPC - Session Highlights
January 18, 2016
ASCO GU 2016 Large Study Reveals Significant Glucocorticoid Use in Both Treated and Untreated Prostate Cancer Patients - Session Highlights (Updated)
January 18, 2016
ASCO GU 2016 Among Treated Men with mCRPC, Researchers Find More Gaps in Refills with Enzalutamide Than Abiraterone - Session Highlights (Updated)
January 18, 2016
ASCO GU 2016 Very early PSA response to abiraterone in mCRPC patients: A novel prognostic factor to predict overall survival. - Poster Session Highlights
January 18, 2016
ASCO GU 2016 Management of metastatic prostate cancer patients in first line: Audit of real-life practices. - Session Highlights
January 18, 2016